Doxycycline combined with MedroxyprogesteroneDoxycycline combined with placebo
Doxycycline combined with Medroxyprogesterone: doxycycline 200 mg/day (100 mg twice daily) combined with medroxyprogesterone acetate(MPA) 24 mg/day (8 mg three times daily) for 14 days
Doxycycline combined with placebo: doxycycline 200 mg/day (100 mg twice daily) with placebo 24 mg/day (8 mg three times daily) for 14 days
Study summary
A Prospective Randomized Controlled Trial, the goal of this clinical trial is to evaluate the efficacy and safety of doxycycline alone versus doxycycline plus medroxyprogesterone acetate (MPA) in women with chronic endometritis (CE), and to assess subsequent reproductive outcomes. Participants will be randomly assigned to one of two groups and will receive the assigned treatment. Participants will be followed for reproductive outcomes, including pregnancy , ongoing pregnancy, spontaneous miscarriage, and live birth.
Eligibility
Sex
FEMALE
Min age
20 Years
Max age
45 Years
Healthy volunteers
No
Inclusion Criteria:
* women aged 20-45 years;
* plans to conceive within 12 months;
* chronic endometritis(CE) confirmed by endometrial CD138 immunohistochemistry (IHC);
* a diagnosis of recurrent reproductive failure(RRF);
* willingness to undergo hysteroscopy and endometrial biopsy;
* no contraindications to the study medications.
Exclusion Criteria:
* acute genital tract infection, gynecologic malignancy, endometrial hyperplasia, or uterine fibroids;
* pregnancy or lactation;
* contraindications to hysteroscopy or anesthesia;
* use of antibiotics, glucocorticoids, estrogens, or progestins within 3 months before trial initiation;
* allergy to doxycycline or medroxyprogesterone acetate(MPA);
* abnormal semen parameters in the male partner.
Primary outcome measure(s)
Cure rate of chronic endometritis — At 8 weeks after completion of treatment
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time on our Cookie Policy page. See also our Privacy Policy.